The University of Chicago Header Logo

Connection

Lynne Kaminer to Waldenstrom Macroglobulinemia

Back to Details
This is a "connection" page, showing publications Lynne Kaminer has written about Waldenstrom Macroglobulinemia.
Lynne Kaminer
Connection Strength
0.059
Waldenstrom Macroglobulinemia
  1. Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98). Leuk Lymphoma. 2004 Oct; 45(10):2047-55.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.